Barry Richard
SEC CIK 1562371 · EDGAR
BoughtSold
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 20:02 | 2026-06-04 | SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Dir | A - Grant | — | +16.9K | 2.98M | +0.6% | — | |
| I | 2025-11-24 | 2025-11-20 | FLNA | FILANA THERAPEUTICS, INC. | Barry Richard | Pres, CEO, Dir | P - Purchase | $2.76 | +150.0K | 938.1K | +19% | +$414.0K |
| I | 2025-11-20 | 2025-11-19 | FLNA | FILANA THERAPEUTICS, INC. | Barry Richard | Pres, CEO, Dir | P - Purchase | $2.75 | +73.4K | 788.1K | +10% | +$201.8K |
| I | 2025-09-23 | 2025-09-22 | FLNA | FILANA THERAPEUTICS, INC. | Barry Richard | Pres, CEO, Dir | P - Purchase | $2.28 | +7,172 | 714.7K | +1% | +$16.4K |
| MI | 2025-09-22 | 2025-09-18+ | FLNA | FILANA THERAPEUTICS, INC. | Barry Richard | Pres, CEO, Dir | P - Purchase | $2.25 | +237.9K | 707.5K | +51% | +$534.7K |
| D | 2025-05-19 | 2025-05-16 | SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Dir | M - OptEx | $32.63 | +12.3K | 2.97M | +0.4% | +$403.0K |
| DM | 2025-05-15 | 2025-05-13 | SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Dir | M - OptEx | $19.23 | +20.2K | 2.95M | +0.7% | +$389.4K |
| D | 2025-03-11 | 2025-03-10 | SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Dir | A - Grant | $0.00 | +2,383 | 2.93M | +0.1% | $0 |
| DI | 2024-04-25 | 2024-04-23 | FLNA | FILANA THERAPEUTICS, INC. | Barry Richard | Dir | M - OptEx | $22.00 | +176.1K | 469.6K | +60% | +$3.87M |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Dir | A - Grant | $0.00 | +1,846 | 2.93M | +0.1% | $0 |
| MI | 2023-11-06 | 2023-11-03 | SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Dir | P - Purchase | $78.81 | +50.0K | 140.0K | +56% | +$3.94M |
| MI | 2023-08-23 | 2023-08-21+ | FLNA | FILANA THERAPEUTICS, INC. | Barry Richard | Dir | P - Purchase | $16.67 | +18.5K | 293.5K | +7% | +$307.9K |
| MI | 2023-03-08 | 2023-03-06+ | FLNA | FILANA THERAPEUTICS, INC. | Barry Richard | Dir | P - Purchase | $25.81 | +88.8K | 197.7K | +82% | +$2.29M |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Dir | A - Grant | $0.00 | +1,523 | 2.93M | +0.1% | $0 |
| I | 2022-08-25 | 2022-08-23 | FLNA | FILANA THERAPEUTICS, INC. | Barry Richard | Dir | P - Purchase | $23.79 | +36.2K | 186.2K | +24% | +$860.2K |
| D | 2022-03-08 | 2022-03-07 | SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Dir | A - Grant | $0.00 | +2,953 | 2.93M | +0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations